Chemical Structure (Talzenna 01)
Talzenna Capsule
Product Images NDC 0069-1501
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Talzenna (NDC 0069-1501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Talzenna 02)
This is a graph that compares the progression-free survival probability of patients between the medications "Talzenna" and "Chemotherapy." The graph displays the number of patients at risk over a timeline ranging from 0 to 39 months.*
Talzenna 02a
Logo (Talzenna 03)
This is a label or packaging information for a product belonging to Pfizer, a pharmaceutical company. The text mentions the name "Pfizer", the company division "Pfizer Labs", and the address of the company's headquarters in New York City. It may represent an over-the-counter or prescription drug distributed by Pfizer.*
Logo (Talzenna 04)
The text is a label from Pfizer pharmaceutical company, indicating that the product was distributed by Pfizer Labs, which is a division of Pfizer Inc. The location of Pfizer Inc. is specified as New York, NY 10017.*
Principal Display Panel (0.25 mg Capsule Bottle Label)
This is a description of medication called Talzenna. It is distributed by Pfizer and comes in capsule form. Each capsule contains 0.25 mg of talazoparib. The dosage and use of Talzenna can be found in the accompanying prescribing information. The medication should be stored between 20°C to 25°C and can be permitted between 15°C to 30°C. It is important to keep Talzenna out of reach of children.*
Principal Display Panel (0.25 Capsule Bottle Carton)
Principal Display Panel (1 mg Capsule Bottle Label)
This is a prescription medication called Talzenna (talazoparib) in capsule form, distributed by Pfizer Labs. Each capsule contains 1mg of talazoparib. The recommended storage temperature is between 15°C to 30°C (59°F to 86°F). Not recommended for children. Dosage and usage instructions are available with the prescribing information that accompanies the product. The print and varnish on the packaging is free from defects.*
Principal Display Panel (1 mg Capsule Bottle Carton)
Talzenna 09
Store the medication Talzenna (talazoparib) capsules at a temperature range of 20°C to 25°C (68°F to 77°F) and excursions between 15°C and 30°C (59°F to 86°F) are allowed. The medication should be kept away from children. Each capsule contains 0.5 mg of talazoparib and is distributed by Pfizer Inc. For more information, refer to the prescribing information.*
Talzenna 10
This is a medication label for Talzenna® (talazoparib) capsules, containing 30 capsules per pack. The label displays the NDC code and advises to keep it out of reach of children. The dosage and use instructions are not available and require reference to an accompanying prescribing information. The manufacturer is Pir Labs, a division of Pl Inc, in New York. The medication is made in Germany and its lot number and expiration date will be printed online.*
Talzenna 11
This is a prescription medication containing Talazoparib which is available in the form of capsules. It is recommended to store it between 20°C to 25°C and can be excused between 15°C to 30°C. The packaging contains 30 capsules with each capsule having a dose of 0.75 mg of Talazoparib. Detailed prescribing information is available with the medication. The medication is distributed by Pfizer Labs and its division Pfizer Inc., NY. Keep it away from the reach of children.*
Talzenna 12
Talzenna(talazoparib) capsules are distributed by Pir Labs and made in Germany. Each capsule contains 0.75 mg talzoparib (equivalent to 1.09 mg azoparib). Please see accompanying prescribing information for dosage and use. The product should be stored between 15-30°C (59-86°F) and kept out of reach of children. The NDC number for Talzenna capsules is 0069-1751-30, and the GTIN is 0030069175130. The text also includes some alphanumeric codes and symbols that could not be interpreted.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
